SEC Form 4 · accession 0000899243-16-027022
BIODELIVERY SCIENCES INTERNATIONAL INC · BDSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Samuel P Sears Jr.
Director
Period of report
Aug 11, 2016
Accepted (ET)
Aug 12, 2016 · 6:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001103021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 11, 2016 | M | 10,000 | $0.00 | A | 61,863 | D | |
| Common Stock | Aug 11, 2016 | M | 15,000 | $0.00 | A | 75,863 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock Units | $0.00 | Aug 11, 2016 | M | 10,000 | D | Aug 11, 2016 | Aug 11, 2016 | Common Stock | 10,000 | 0 | D |
| Restricted Stock UnitsF2 | $0.00 | Aug 11, 2016 | M | 15,000 | D | Aug 11, 2016 | — | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The shares of common stock were acquired by the Reporting Person as a result of the vesting of 10,000 Restricted Stock Units ("RSUs") granted to the Reporting Person on July 16, 2015 under the Issuer's 2011 Equity Incentive Plan, as amended.
- F2The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-half of the RSUs granted to the Reporting Person on June 30, 2016 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs under this grant will vest in the first open window following the Company's 2017 Annual Meeting of Stockholders.